Its administration vaccine from Pfizer Inc against COVID-19 was approved in Canada and in children aged 12 to 15 years.
These are the first doses of vaccine allowed in the country for people of such a young age, as announced yesterday, Wednesday, the federal Ministry of Health.
Supriya Sarma, a senior adviser at the Canadian Federal Ministry of Public Health, said the Pfizer vaccine, produced in collaboration with Germany’s BioNTech SE, is safe and effective in this age group.
“We are starting to see the light at the end of the tunnel,” she told reporters, as broadcast by AMPE.
Sarma and a Health Department spokesman said Canada was the first country to grant such approval, but a Pfizer spokesman in Canada later said Algeria approved the vaccine in April in April.
The US Federal Food and Drug Administration is expected to take a similar step “very soon”, US health officials said.
In a separate development, authorities announced the third death of a Canadian, from a rare thrombosis after receiving the AstraZeneca PLC vaccine against COVID-19.
The man was 60 years old and lived in the province of New Brunswick on the Atlantic coast.
Jennifer Russell, a health official in the county, said the use of AstraZeneca vaccine will be continued. The Canadian province of Alberta reported a death from thrombosis on Tuesday, while the province of Quebec announced a similar death on April 27.
“There will be rare cases of thrombosis. However, the risks remain small, compared to the risks, complications and possible consequences of COVID-19, “said Russell.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
